bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - maladie pulmonaire, chronique obstructive - de formotérol et de bromure de glycopyrronium - bevespi aerosphere est indiqué comme traitement bronchodilatateur d'entretien pour soulager les symptômes chez les patients adultes atteints de maladie pulmonaire obstructive chronique (mpoc).
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - maladie pulmonaire, chronique obstructive - les médicaments pour les maladies respiratoires obstructives, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
breztri aerosphere aérosol, dose mesurée
astrazeneca canada inc - budésonide; glycopyrronium (bromure de glycopyrronium); fumarate de formotérol dihydraté - aérosol, dose mesurée - 160mcg; 7.2mcg; 5mcg - budésonide 160mcg; glycopyrronium (bromure de glycopyrronium) 7.2mcg; fumarate de formotérol dihydraté 5mcg - antimuscarinics antispasmodics
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - maladie pulmonaire, chronique obstructive - les médicaments pour les maladies respiratoires obstructives, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
axotide 0,125 mg dosage des aérosols (cfc)
glaxosmithkline ag - fluticasoni propionas - dosage des aérosols (cfc) - fluticasoni propionas 125 µg pro dosi, propellentia ad aerosolum. doses pro vase 120. - antiasthmatikum - synthetika
axotide 0,250 mg dosage des aérosols (cfc)
glaxosmithkline ag - fluticasoni propionas - dosage des aérosols (cfc) - fluticasoni propionas 250 µg pro dosi, propellentia ad aerosolum. doses pro vase 120. - antiasthmatikum - synthetika
axotide 0,050 mg dosage des aérosols (cfc)
glaxosmithkline ag - fluticasoni propionas - dosage des aérosols (cfc) - fluticasoni propionas 50 µg pro dosi, propellentia ad aerosolum. doses pro vase 120. - antiasthmatikum - synthetika
ventolin dosier aérosol
glaxosmithkline ag - salbutamolum - dosier aérosol - salbutamolum 100 µg ut salbutamoli sulfas, norfluranum ad aerosolum pro dosi, doses pro vase 200. - bronchospasmolyticum - synthetika
qvar autohaler 50 µg dosier aérosol
teva pharma ag - beclometasoni dipropionas - dosier aérosol - beclometasoni dipropionas 50 µg, ethanolum anhydricum 4.74 mg, norfluranum ad aerosolum pro dosi. - antiasthmatikum - synthetika
qvar autohaler 100 µg dosier aérosol
teva pharma ag - beclometasoni dipropionas - dosier aérosol - beclometasoni dipropionas 100 µg, ethanolum anhydricum 4.74 mg, norfluranum ad aerosolum pro dosi. - antiasthmatikum - synthetika